Clinical trial
Angiosome Perfusion After Tibial Bypass
NCT03012750 is registered in ClinicalTrials.gov with University Hospital Erlangen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Angiosome Perfusion After Tibial Bypass
- Lead sponsor
- University Hospital Erlangen
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 28, 2015
- Completion date
- October 31, 2016
- Enrollment
- 40 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.